US 9708386
Modified chimeric polypeptides with improved pharmacokinetic properties
granted A61KA61K38/00A61P
Quick answer
US patent 9708386 (Modified chimeric polypeptides with improved pharmacokinetic properties) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00, A61P, A61P43/00